Stericycle, Inc. (NASDAQ:SRCL) Shares Bought by Strategic Blueprint LLC

Strategic Blueprint LLC lifted its stake in Stericycle, Inc. (NASDAQ:SRCL) by 6.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,609 shares of the business services provider’s stock after acquiring an additional 326 shares during the period. Strategic Blueprint LLC’s holdings in Stericycle were worth $278,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in SRCL. JPMorgan Chase & Co. lifted its stake in shares of Stericycle by 42.2% in the 1st quarter. JPMorgan Chase & Co. now owns 2,808,202 shares of the business services provider’s stock worth $122,466,000 after acquiring an additional 833,215 shares during the period. Lazard Asset Management LLC acquired a new stake in shares of Stericycle in the 4th quarter worth approximately $29,286,000. Ninety One UK Ltd acquired a new stake in shares of Stericycle in the 3rd quarter worth approximately $22,644,000. Millennium Management LLC acquired a new stake in shares of Stericycle in the 4th quarter worth approximately $24,363,000. Finally, Point72 Asset Management L.P. lifted its stake in shares of Stericycle by 55,818.2% in the 2nd quarter. Point72 Asset Management L.P. now owns 445,668 shares of the business services provider’s stock worth $20,697,000 after acquiring an additional 444,871 shares during the period. 98.82% of the stock is owned by institutional investors and hedge funds.

Stericycle Stock Performance

Shares of NASDAQ:SRCL opened at $49.26 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.94 and a current ratio of 0.94. Stericycle, Inc. has a 52 week low of $37.78 and a 52 week high of $57.06. The firm has a 50 day simple moving average of $51.32 and a 200 day simple moving average of $47.81.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Wednesday, February 28th. The business services provider reported $0.54 EPS for the quarter, beating the consensus estimate of $0.47 by $0.07. The business had revenue of $652.00 million during the quarter, compared to the consensus estimate of $657.99 million. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The firm’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.60 EPS. Research analysts forecast that Stericycle, Inc. will post 2.31 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $69.00 price target on shares of Stericycle in a research note on Thursday, March 7th. Truist Financial increased their target price on shares of Stericycle from $50.00 to $57.00 and gave the company a “hold” rating in a research note on Thursday, February 29th. StockNews.com lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Tuesday, April 2nd. Stifel Nicolaus increased their target price on shares of Stericycle from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 29th. Finally, Wells Fargo & Company increased their target price on shares of Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a research note on Friday, March 1st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Stericycle currently has an average rating of “Hold” and a consensus price target of $62.25.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.